These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 11531794

  • 1. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P, Moraru E, Kittler H, Binder M, Kranz G, Voller B, Auff E.
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
    Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM.
    Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S, Macaluso L, Salvi M, Luci C, Mattozzi C, Marzocca F, Salvo V, Scarnò M, Calvieri S, Richetta AG.
    Clin Ter; 2014 Nov; 165(6):e395-400. PubMed ID: 25524193
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin.
    Swartling C, Naver H, Pihl-Lundin I, Hagforsen E, Vahlquist A.
    J Am Acad Dermatol; 2004 Nov; 51(5):739-45. PubMed ID: 15523352
    [Abstract] [Full Text] [Related]

  • 13. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK, Hamm H, Lowe NJ, Botox Hyperhidrosis Clinical Study Group.
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [Abstract] [Full Text] [Related]

  • 14. Evidence-based medicine: botulinum toxin in focal hyperhidrosis.
    Naumann M.
    J Neurol; 2001 Apr; 248 Suppl 1():31-3. PubMed ID: 11357238
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox.
    Glogau RG.
    Dermatol Surg; 1998 Aug; 24(8):817-9. PubMed ID: 9723044
    [Abstract] [Full Text] [Related]

  • 17. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
    Odderson IR.
    Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.
    Lecouflet M, Leux C, Fenot M, Célerier P, Maillard H.
    J Am Acad Dermatol; 2014 Jun; 70(6):1083-7. PubMed ID: 24630001
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.